These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16365961)

  • 1. Canadian developments. Buprenorphine now approved for the treatment of opiate addiction.
    Garmaise D
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):20, 22. PubMed ID: 16365961
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving use of buprenorphine in the treatment of addiction.
    Martin J
    J Psychoactive Drugs; 2004 May; Suppl 2():129-37. PubMed ID: 15279125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
    Resnick RB
    Ann Intern Med; 2003 Feb; 138(4):360. PubMed ID: 12585846
    [No Abstract]   [Full Text] [Related]  

  • 4. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 6. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
    Saloner B; Stoller KB; Alexander GC
    N Engl J Med; 2018 Jul; 379(1):4-6. PubMed ID: 29972745
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine: a new treatment for opioid addiction.
    Harv Ment Health Lett; 2001 Feb; 17(8):6-7. PubMed ID: 11175458
    [No Abstract]   [Full Text] [Related]  

  • 9. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 10. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 12. New pharmacological tool approved for opioid addiction.
    Sansovich D
    HIV Clin; 2004; 16(3):9-11. PubMed ID: 15366107
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine diffusion: the attitudes of substance abuse treatment counselors.
    Knudsen HK; Ducharme LJ; Roman PM; Link T
    J Subst Abuse Treat; 2005 Sep; 29(2):95-106. PubMed ID: 16135338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative implications of buprenorphine maintenance treatment for opioid addiction.
    Gevirtz C; Frost EA; Bryson EO
    Int Anesthesiol Clin; 2011; 49(1):147-55. PubMed ID: 21239911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
    Radomska M; Pach J; Chrostek Maj J
    Przegl Lek; 2001; 58(4):351-3. PubMed ID: 11450367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option.
    Vastag B
    JAMA; 2003 Aug; 290(6):731-5. PubMed ID: 12915410
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice].
    Sofronov AG; Kuz'min AV; Pchelintsev MV; Belogurov SB
    Anesteziol Reanimatol; 1994; (4):13-5. PubMed ID: 7802310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.